Attached files
file | filename |
---|---|
EX-10.1 - Earth Science Tech, Inc. | ex10-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 23, 2017
EARTH SCIENCE TECH, INC. |
(Exact Name of Registrant as Specified in its Charter) |
Nevada |
(State or Other Jurisdiction of Incorporation) |
000-55000 | 45-4267181 | |
(Commission
File Number) |
(IRS
Employer Identification No.) |
8000 NW 31st Street, Suite 19 Doral, FL |
33122 | |
(Address of Principal Executive Offices) | (Zip Code) |
(Registrant’s telephone number, including area code): (305) 615-2118
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01. Entry into Material Definitive Agreement.
Service Agreement: Letter of Mandate for the Formulation Service of 3 syrups based on Hemp Oil
On January 27, 2017, The Registrant executed a letter agreement with Smart Medicines GMP of Quebec, Canada (“Smart Medicines”) for the formulation of 3 new syrups based on hemp oil. The Registrant’s cost for these services was $45,000 CAD plus taxes paid in installments by May 1, 2017.
Smart Medicines’ lab is enrolled in the World Health Organization Good Manufacturing Process (WHO-GMP), which is a system for ensuring that products are consistently produced and controlled according to quality standards, and the services and products coming out of the lab are insured up to $2 million CAD.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. | Description of Document | |
10.1 | Letter of Mandate for the Formulation Service of 3 syrups based on Hemp Oil from Smart Medicines GMP to the Registrant |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EARTH SCIENCE TECH, INC. | |
Dated: November 9, 2017 | /s/ Nickolas S. Tabraue |
Nickolas S. Tabraue | |
President and COO |